2012 PharmEHR Summit March 20 & 21, Philadelphia

Delivering Bio/Pharmaceutical Marketing and Regulatory Results Using Electronic Health Records (EHRs):
Messages to Physicians at the Point of Prescribing and Care

Philadelphia Hyatt at the Bellevue, March 20-21, 2012

For more information, please contact PDR Network representative Thomas Eck at (201) 358-7424 or via email at thomas.eck@pdr.net.

This exclusive, invitation-only event will feature industry-leading speakers from Bio/Pharma; the federal government, including Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA; and EHR vendor firms, including Glen Tullman, CEO of Allscripts, the country’s largest EHR vendor.

Industry leaders will discuss, demonstrate and design practical means to deliver drug safety, risk management, patient support, marketing services and regulatory messages within physician workflow via EHRs. Key areas of discussion will include:
• EHR adoption and the powerful impact on physician decision-making: “The New MD Desktop”
• Regulatory and brand message integration into the new physician workflow
• Improving prescription fulfillment and medication adherence


About the PharmEHR® Summit

Tuesday, March 20
11:00 AM
Arrivals & Lunch

12:00 PM
Welcome and 2011 EHR Look-back

12:30 PM
EHRs: What, Why and Where
EHR Adoption, Drivers and Impact

1:30 PM
Impact of EHRs on the Medical-Legal- Regulatory Framework and the ‘Duty-to-Warn’ Landscape

2:15 PM
Break (15 minutes)

2:30 PM
ePrescribing Adoption, Formulary Compliance

3:15 PM
Integrating EHRs into the Product Marketing Lifecycle

4:15 PM
EHRs – Payer's Perspective

5:00 PM
Break

5:30 PM
Top 100 Wine Tasting

7:00 PM
Dinner Key Note: EHRs - Now and the Near Future
• Glen Tullman, CEO, Allscripts

Wednesday, March 21
7:00 AM
Breakfast

7:45 AM
Welcome & Agenda

8:00 AM
What EHRs Currently Offer Pharma

9:00 AM
What Pharma Wants from EHRs and Their Users

10:00 AM
Break (15 minutes)

10:15 AM
EHRs and Adverse Drug Event Reporting and Follow-up

11:00 AM
EHR Patient Connectivity: Driving Medication Adherence and Safety

12:00 PM
Lunch

1:00 PM
Day Two Key Note: EHRs and FDA Goals: Safety and Adherence
• Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA

1:45 PM
Bringing REMS and Adherence to Life with EHRs

2:30 PM
Closing Remarks/Meeting Adjourns

PDR Network recognized early the significant impact of EHR adoption on the bio/pharmaceutical industry. In addition to leading in the integration of drug-related services into EHRs, PDR Network founded the PharmEHR® Summit – the only national meeting of senior executives from bio/pharma and EHRs. Each year, this invitation-only meeting explores emerging strategies for bio/pharmaceutical marketing, regulatory and other core business objectives.

In hosting the annual PharmEHR® Summit, PDR Network reinforces its commitment as a strategic leader and trusted partner within the healthcare community.

PDR Network